Nanotherapeutics

Your Biopharmaceutical Development and Manufacturing Partner

Nanotherapeutics and the Vaccine Branch of the National Cancer Institute enter into Cooperative Research and Development Agreement (CRADA)

Yahoo Finance! / www.nanotherapeutics.com - August 2007

Nanotherapeutics, Inc. has entered into a two year Cooperative Research and Development Agreement (CRADA) with the Vaccine Branch of the National Cancer Institute (NCI) to produce HIV peptide oral vaccine nanoparticles using the company's proprietary technology. The collaboration with NCI will employ the company's nanoparticle delivery system, which enables oral targeted delivery of macromolecules such as peptides, to facilitate oral delivery in the GI tract to improve immune response.

Full Article

Copyright 2016 NANOTHERAPEUTICS, INC.  All rights reserved.